Marker Therapeutics Inc (MRKR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 11,006 | 10,024 | 10,909 | 8,781 | 8,509 |
| Operating Income | -9,764 | -10,024 | -10,909 | -8,781 | -8,509 |
| Other Income | 1 | -2,406 | 2 | 2 | 1 |
| Pre-tax Income | -9,763 | -12,429 | -10,907 | -8,779 | -8,507 |
| Net Income Continuous | -9,763 | -12,429 | -10,907 | -8,779 | -8,507 |
| Net Income | $-9,763 | $-12,429 | $-10,907 | $-8,779 | $-8,507 |
| EPS Basic Total Ops | -1.07 | -1.50 | -1.30 | -1.60 | -1.70 |
| EPS Basic Continuous Ops | -1.11 | -1.50 | -1.31 | -1.55 | -1.76 |
| EPS Diluted Total Ops | -1.07 | -1.50 | -1.30 | -1.60 | -1.70 |
| EPS Diluted Continuous Ops | -1.11 | -1.50 | -1.31 | -1.55 | -1.76 |
| EBITDA(a) | $-10,186 | $-9,218 | $-10,126 | $-8,027 | $-8,043 |